Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Halstensen, M. Ceska, P. Brandtzaeg, H. Redl, A. Næss, A. Waage (1993)
Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.The Journal of infectious diseases, 167 2
A. Marchant, Michel Goldman, J. Devière, B. Byl, J. Vincent, D. Groote (1994)
Interleukin-10 production during septicaemiaThe Lancet, 343
D. Helfgott, S. Tatter, U. Santhanam, R. Clarick, N. Bhardwaj, L. May, P. Sehgal (1989)
Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.Journal of immunology, 142 3
A. Waage, P. Brandtzaeg, A. Halstensen, P. Kierulf, T. Espevik (1989)
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcomeThe Journal of Experimental Medicine, 169
Michael Rogy, S. Coyle, H. Oldenburg, C. Rock, P. Barie, Van Kj, Smith Cg, L. Moldawer, Stephen Lowry (1994)
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.Journal of the American College of Surgeons, 178 2
A. Waage, A. Halstensen, T. Espevik (1987)
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 329
C. Hack, M. Hart, R. Schijndel, A. Eerenberg, H. Jan, Nuijens, L. Thijs, A. Lucien, Aarden (1992)
Interleukin-8 in sepsis: relation to shock and inflammatory mediatorsInfection and Immunity, 60
C. Martin, P. Saux, J. Mege, G. Perrin, L. Papazian, F. Gouin (2005)
Prognostic values of serum cytokines in septic shockIntensive Care Medicine, 20
Joseph Cannon, R. Tompkins, J. Gelfand, H. Michie, G. Stanford, J. Meer, S. Endres, G. Lonnemann, J. Corsetti, B. Chernow, D. Wilmore, S. Wolff, J. Burke, C. Dinarello (1990)
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.The Journal of infectious diseases, 161 1
J. Marks, C. Marks, John Ljuce, A. Montgomery, J. Turner, C. Metz, J. Murray (1990)
Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.The American review of respiratory disease, 141 1
L. Casey, R. Balk, R. Bone (1993)
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis SyndromeAnnals of Internal Medicine, 119
E. Girardin, G. Grau, J. Dayer, P. Roux‐Lombard, P. Lambert (1988)
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.The New England journal of medicine, 319 7
M. Groote, MichaelA. Martin, P. Densen, M. Pfaller, R. Wenzel (1989)
Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.JAMA, 262 2
P. Damas, A. Reuter, P. Gysen, J. Demonty, M. Lamy, P. Franchimont (1989)
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.Critical care medicine, 17 10
Andrew Bean, R. Freiberg, Sylvia Andrade, Satish Menon, Albert Zlotnik (1993)
Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shockInfection and Immunity, 61
Jon Friedland, Y. Suputtamongkol, Daniel Remick, W. Chaowagul, R. Strieter, S. Kunkel, N. White, George Griffin (1992)
Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infectionInfection and Immunity, 60
(1994)
Soluble interleukin - 6 ( IL - 6 ) receptor levels in septic patients and relation with circulating IL - 6
T. Calandra, J. Gérain, D. Heumann, J. Baumgartner, M. Glauser (1991)
High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.The American journal of medicine, 91 1
Richelle, F. J., Felt-Bersma, Jan, H., Nuijens, Rob, M. J., Strack, Van, Schijndel, Anke, Eerenberg-Belmer, Lambertus, G., Thijs (1989)
Increased plasma levels of interleukin-6 in sepsis.Blood, 74 5
E. Girardin, P. Roux‐Lombard, G. Grau, P. Suter, H. Gallati, J. Dayer (1992)
Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.Immunology, 76 1
(1988)
RouxLombard P, the J 5 Study
Sylvie Chollet-Martin, Philippe Montravers, Claude Gibert, C. Elbim, J. Desmonts, J. Fagon, M. Gougerot-Pocidalo (1993)
High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndromeInfection and Immunity, 61
M. Howard, T. Muchamuel, Sílvia Andrade, S. Menon (1993)
Interleukin 10 protects mice from lethal endotoxemiaThe Journal of Experimental Medicine, 177
T. Poll, J. Jansen, Diana Leenen, Marijke Mohlen, M. Levi, H. Cate, H. Gallati, J. Cate, S. Deventer (1993)
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.The Journal of infectious diseases, 168 4
Slutsky As (1994)
Consensus conference on mechanical ventilation--January 28-30, 1993 at Northbrook, Illinois, USA. Part I. European Society of Intensive Care Medicine, the ACCP and the SCCM.Intensive Care Medicine, 20
T. Calandra, J. Baumgartner, G. Grau, Meiqiong Wu, P. Lambert, J. Schellekens, J. Verhoef, M. Glauser (1990)
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 161
C. Muñoz, B. Misset, C. Fitting, J. Blériot, Jean‐Carlet, J. Cavaillon (1991)
Dissociation between plasma and monocyte‐associated cytokines during sepsisEuropean Journal of Immunology, 21
J. Debets, René Kampmeijer, M. P, Wim Buurman, CEES LINDEN (1989)
Plasma tumor necrosis factor and mortality in critically ill septic patients.Critical care medicine, 17 6
C. Wortel, M. Möhlen, S. Deventer, C. Sprung, M. Jastremski, M. Lubbers, Craig Smith, Isabel Allen, J. Cate (1992)
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.The Journal of infectious diseases, 166 6
Pierre Dama, D. Ledoux, M. Nys, Y. Vrindts, D. Groote, P. Franchimont, M. Lamy (1992)
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.Annals of surgery, 215 4
C. Hack, E. Groot, R. Felt‐Bersma, J. Nuijens, RJ Schijndel, Aj Eerenberg-Belmer, LG Thijs, L. Aarden (1989)
Increased plasma levels of interleukin-6 in sepsis [see comments]Blood, 74
M. Pinsky, M. Pinsky, J. Vincent, J. Devière, M. Alegre, R. Kahn, E. Dupont (1993)
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.Chest, 103 2
E. Fischer, K. Zee, Michael Marano, C. Rock, John Kenney, D. Poutsiaka, C. Dinarello, Stephen Lowry, L. Moldawer (1992)
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.Blood, 79 9
J. Philippé, G. Dooijewaard, Fritz Offner, P. Turion, Gaston Baele, G. Leroux-Roels (1992)
Granulocyte Elastase, Tumor Necrosis Factor-α and Urokinase Levels as Prognostic Markers in Severe InfectionThrombosis and Haemostasis, 68
134 21 21 2 2 L. G. Thijs C. E. Hack Medical Intensive Care Unit and Institute for Cardiovascular Research (ICaR-VU) Free University Hospital P.O. Box 7057 NL-1007 MB Amsterdam The Netherlands Central Laboratory of the Netherlands Red Cross Blood Transfusion Service Amsterdam The Netherlands Abstract In severe sepsis, a network of proinflammatory cytokines (TNF, IL-lß, IL-6, IL-8) is activated and blood levels of these cytokines are elevated, albeit inconsistently and with large individual variations. In addition, elevated blood levels of anti-inflammatory cytokines (IL-10), as well as of soluble cytokine receptors (sTNF-RI and II, IL-lra), have been found. They seem to have a regulatory function in the host response. Levels of TNF and IL-6 are usually highest at the time of admission, whereas the time course of IL-lß levels (when detectable) can vary considerably. Limited data on IL-8 levels suggest that they may remain elevated for longer periods. Elevated levels of sTNFR and IL-lra may also persist for a prolonged period of time. The pathogenetic significance of these observations is still unclear, but persistingly high levels of proinflammatory cytokines may be associated with organ failure and mortality.
Intensive Care Medicine – Springer Journals
Published: Nov 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.